PANICCIA, RITA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.744
EU - Europa 9.524
AS - Asia 3.625
SA - Sud America 487
AF - Africa 128
OC - Oceania 96
Continente sconosciuto - Info sul continente non disponibili 2
Totale 23.606
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.627
PL - Polonia 3.712
RU - Federazione Russa 2.062
IT - Italia 1.518
SG - Singapore 1.073
CN - Cina 756
HK - Hong Kong 589
IE - Irlanda 533
SE - Svezia 496
VN - Vietnam 443
BR - Brasile 389
DE - Germania 315
KR - Corea 299
UA - Ucraina 238
FI - Finlandia 203
GB - Regno Unito 172
FR - Francia 163
IN - India 107
AU - Australia 92
CA - Canada 65
BD - Bangladesh 53
JP - Giappone 47
ID - Indonesia 41
JO - Giordania 41
TR - Turchia 41
AR - Argentina 38
IQ - Iraq 28
NL - Olanda 28
CI - Costa d'Avorio 26
ES - Italia 20
MX - Messico 20
PK - Pakistan 18
ZA - Sudafrica 18
BE - Belgio 15
EC - Ecuador 15
NG - Nigeria 15
MA - Marocco 14
TN - Tunisia 12
VE - Venezuela 12
SA - Arabia Saudita 10
CO - Colombia 9
OM - Oman 9
DK - Danimarca 8
EG - Egitto 8
KE - Kenya 8
TW - Taiwan 8
CL - Cile 7
CZ - Repubblica Ceca 7
DZ - Algeria 7
PE - Perù 7
PH - Filippine 7
SC - Seychelles 7
TH - Thailandia 7
UZ - Uzbekistan 7
BJ - Benin 6
CR - Costa Rica 6
LT - Lituania 6
BG - Bulgaria 5
CH - Svizzera 5
KZ - Kazakistan 5
MY - Malesia 5
UY - Uruguay 5
CU - Cuba 4
DO - Repubblica Dominicana 4
HN - Honduras 4
JM - Giamaica 4
LB - Libano 4
LV - Lettonia 4
NZ - Nuova Zelanda 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
AZ - Azerbaigian 3
IR - Iran 3
MN - Mongolia 3
NP - Nepal 3
SN - Senegal 3
SV - El Salvador 3
AL - Albania 2
GE - Georgia 2
MU - Mauritius 2
NO - Norvegia 2
PA - Panama 2
RO - Romania 2
TT - Trinidad e Tobago 2
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
DM - Dominica 1
EU - Europa 1
GA - Gabon 1
GR - Grecia 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
Totale 23.598
Salva come PNG Salva come JPEG
Città #
Warsaw 3.706
Santa Clara 2.079
Ashburn 1.002
Fairfield 912
Singapore 774
Chandler 556
Dublin 531
Hong Kong 470
Woodbridge 388
Jacksonville 371
Seattle 365
Houston 321
Cambridge 317
Wilmington 296
Seoul 287
Milan 282
Florence 207
San Jose 202
Beijing 193
Ann Arbor 173
Princeton 146
Ho Chi Minh City 134
Rome 129
Buffalo 128
Lawrence 123
Altamura 122
The Dalles 118
Lauterbourg 111
Boardman 97
Hanoi 97
Los Angeles 93
Medford 93
Melbourne 84
Council Bluffs 79
New York 79
Moscow 75
Hefei 74
Boston 71
Mumbai 71
Helsinki 64
San Diego 61
Shanghai 54
Munich 52
Dallas 45
Dong Ket 44
London 38
São Paulo 38
Tokyo 38
Naples 35
Jakarta 33
Bologna 31
Figino 31
Phoenix 30
Norwalk 27
Abidjan 26
Turin 26
Izmir 22
Toronto 22
Kent 21
Redondo Beach 20
Da Nang 17
Andover 16
Brescia 16
Chicago 16
Orem 16
Palermo 16
Haiphong 15
Paris 15
Brussels 14
Falls Church 14
Latina 14
Washington 14
Auburn Hills 13
Clifton 13
Tianjin 13
Bari 12
Guangzhou 12
Miano 12
Montreal 12
Turku 12
Verona 12
Brooklyn 11
Hillsboro 11
Padua 11
Rio de Janeiro 11
Barcelona 10
Belo Horizonte 10
Frankfurt Am Main 10
Frankfurt am Main 10
Utrecht 10
Yubileyny 10
Abuja 9
Baghdad 9
Genoa 9
Amman 8
Atlanta 8
Cagliari 8
Campinas 8
Dhaka 8
Johannesburg 8
Totale 16.587
Salva come PNG Salva come JPEG
Nome #
Assessment of platelet function: Laboratory and point-of-care methods 380
Binding kinetics and antiplatelet activities of picotamide, a thromboxane A2 receptor antagonist. 375
Thromboxane inhibition improves renal perfusion and excretory function in severe congestive heart failure 364
Plasma levels of direct oral anticoagulants in real life patients with atrial fibrillation: Results observed in four anticoagulation clinics 363
Cardiac growth factors in human hypertrophy. Relations with myocardial contractility and wall stress 362
High on-treatment platelet reactivity by ADP and increased risk of MACE in good clopidogrel metabolizers. 360
Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events. 356
High platelet turnover and reactivity in renal transplant recipients patients 347
Platelet Function tests: A Comparative Review 346
Characterization of endothelin-1 receptor subtypes in isolated human cardiomyocytes. 342
Index measured at an intermediate altitude to predict impending acute mountain sickness 324
Effect of blood hematocrit and erythrocyte deformability on adenosine 5' -diphosphate platelet reactivity in patients with acute coronary syndromes on dual antiplatelet therapy 317
Increased renal formation of thromboxane A 2 and prostaglandin F 2α in heart failure 314
Selective Upregulation of Cardiac Endothelin System in Patients With Ischemic but Not Idiopathic Dilated Cardiomyopathy. Endothelin-1 System in the Human Failing Heart 313
Bioequivalence in the real world is a complex challenge: the case of clopidogrel 312
Platelet aggregability is modulated by eNOS locus in non-type 2 diabetic patients with acute coronary syndrome 309
Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosis 305
Effect of low-dose heparin treatment on fibrinolysis in patients with previous myocardial infarction 303
Aumentata produzione di trombossano A2 e di PGE2 con normale conversione di 1-14 C acido arachidonico da parte delle piastrine nei soggetti diabetici. 291
Role of glycoprotein Ia gene polymorphisms in determinino platelet function in myocardial infarction patients undergoing percutaneous coronary intervention of dual antiplatelet treatment 290
Residual platelet reactivity is associated with clinical and laboratory characteristics in patients with ischemic heart disease undergoing PCI on dual antiplatelet therapy 287
Cardiac growth factors in human hypertrophy. Relations with myocardial contractility and wall stress. 286
The balance between pro- and anti-infilammatory cytokines is associated with platelet aggregability in acute coronary syndrome patients 283
Perioperative assessment of platelet function by Thromboelastograph Platelet MappingTM in cardiovascular patients undergoing non-cardiac surgery 278
Residual thrombin potential predicts cardiovascular death in acute coronary syndrome patients undergoing percutaneous coronary intervention 278
Platelet and leukocyte ROS production and lipoperoxidation are associated with high platelet reactivity in Non-ST elevation myocardial infarction (NSTEMI) patients on dual antiplatelet treatment 274
Thrombotic events in high risk patients are predicted by evaluating different pathways of platelet function. 264
Hign on treatment platelet reactivity by more than one agonist predicts 12-month follow-up cardiovascular death and non-fatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting 243
Point-of-care testing of hemostasis in cardiac surgery 231
ADAMTS-13 activity in the presence of elevated von Willebrand factor levels as a novel mechanism of residual platelet reactivity in high risk coronary patients on antiplatelet treatment 209
Prostaglandins in squamous cell carcinoma of the larynx: tumor and peritumor synthesis 200
Platelet synthesis of cyclooxygenase and lipoxygenase products in type I and type II diabetes 200
A time course study of high on treatment platelet reactivity in acute coronary syndrome male patients on dual antiplatelet therapy. 200
Platelet Reactivity in Hepatitis C Virus-Infected Patients on Dual Antiplatelet Therapy for Acute Coronary Syndrome 199
Assessment of platelet function on whole blood by multiple electrode aggregometry in high-risk patients with coronary artery disease receiving antiplatelet therapy 196
S-100 protein and neuron-specific enolase as markers of subclinical cerebral damage after cardiac surgery: Preliminary observation of a 6-month follow-up study 191
Age related changes in platelet lipid composition 189
High on-aspirin platelet reactivity predicts cardiac death in acute coronary syndrome patients undergoing PCI 189
Fibrin generation and digestion in patients with angina pectoris 180
Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12 month follow-up 177
Altered membrane fatty acid composition and increased thromboxane A2 generation in platelets from patients with diabetes 177
Relationship between classical FDP test and D-dimer assayed both by latex agglutination and ELISA 175
No signs of increased thrombin generation in menopause 175
Evaluation of clotting and fibrinolytic activation after protracted physical exercise 172
Cyclooxygenase and lipoxygenase metabolite synthesis by polymorphonuclear neutrophilis: in vitro effect of dipyrone 172
Effect of low-dose heparin on fibrinogen levels in patients with chronic ischemic heart disease. 169
Effect of medium-term supplementation with a moderate dose of n-3 polyunsaturated fatty acids on blood pressure in mild hypertensive patients 168
Cyclooxygenase and lipoxygenase metabolite generation in nasal polyps 168
On-Treatment Platelet Reactivity is a Predictor of Adverse Events in Peripheral Artery Disease Patients Undergoing Percutaneous Angioplasty 167
Incidence and clinical impact of dual nonresponsiveness to aspirin and clopidogrel in patients with drug-eluting stents 165
Early sequence of cardiac adaptations and growth factor formation in pressure- and volume-overload hypertrophy 165
Anticoagulant effect of dabigatran, rivaroxaban or apixaban treatment on different laboratory hemostasis tests in patients with atrial fibrillation 165
Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4IVS10+12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients. 163
Age-related changes in red blood cell lipids 162
Exercise-induced tissue plasminogen activator increase: a role for metabolic acidosis. 162
Acitivty of dipyrone on intraplatelet arachidonic acid metabolism: an in vitro study 161
Clinical Implications of “Tailored” Antiplatelet Therapy in Patients With Chronic Total Occlusion 161
Red blood cell lipid alterations in type II diabetes mellitus. 160
Time-sequence activation and relationship with cardiac functon of angiotensinogen, endothelin-1 and insulin-like growth factor-I gene expression in acutely overloaded pigs 160
Residual platelet reactivity to predict long-term clinical outcomes after clopidogrel loading in patients with acute coronary syndromes: comparison of different cutoff values by light transmission aggregometry from the responsiveness to clopidogrel and stent thrombosis 2-acute coronary syndrome (RECLOSE 2-ACS) study 160
Effect of oral treatment with pantethine on platelet and plasma phospholipids in IIa hyperlipoproteinemia 158
Evaluation of a new point-of-care celite-activated clotting time analyzer in different clinical settings. The i-STAT celite-activated clotting time test. 157
Endothelin receptors in adult human and swine isolated ventricular cardiomyocytes. 156
Increased thromboxane A2 production at primary tumor site in metastasizing squamous cell carcinoma of the larynx 155
Effect of temperature and incubation time on D-dimer serum levels in healthy subjects. 154
Comparison of different methods to evaluate the effect of aspirin on platelet function in high-risk patients with ischemic heart disease receiving dual antiplatelet treatment. 153
Haemostasis and Cytokines Modifications in Elite Cyclists 150
Residual platelet reactivity is an independent predictor of myocardial injury in acute myocardial infarction patients on antiaggregant therapy. 150
Lipid, inflammatory, and haemorheological profiles are significantly affected by farmed fish eating: an intervention study 149
Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis. 149
Monitoring platelet function in coronary heart disease patients on clopidogrel therapy: whole blood multiplate impedance aggregometer compared to classical and new platelet function methods 147
Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy 146
Influence of dabigatran, rivaroxaban or apixaban treatment on hemostasis point-of-care testing (POCT) in patients with atrial fibrillation. 146
Post-PCI thrombin generation and cardiovascular mortality in acute coronary syndrome patients 145
Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study. 145
Accuracy of a Point-of-Care system for PT/INR test performed in the hospital anticoagulation clinic 143
D-dimer plasma levels in pathological pregnancy: use of a rapid test (NycoCard). 142
THROMBOELASTOMETRIC ASSAY FOR MONITORING HEMOSTASIS DURING EXTRACORPOREAL MEMBRANE OXYGENATION IN ACUTE RESPIRATORY DISTRESS SYNDROME PATIENTS 141
Impaired Ang II mediated activation of ERK1/ERK2 and SAPK/JNK pathways with normal AT1 receptor binding and mRNA expression in myocytes from failing human hearts 141
Prostaglandins (PG) and Cervical Metastases in laringea cancer 141
Nasal polyps in allergic and non-allergic rhinitis: role of arachidonic acid metabolites 140
Platelet activation and platelet lipid composition in pulmonary cancer 139
Relationship between plasma and platelet phospholipid fatty acid composition in healthy subjects 139
Non-traumatic splenic rupture on dual antiplatelet therapy with aspirin and ticagrelor after stenting for acute coronary syndrome 139
Euglobulin lysis time in fresh and storedi samples 138
Altered lipid composition and thromboxane A2 formation in platelets from patients affected by II Hyperlipoproteinemia. 138
Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. 137
Low-dose heparin as an antithrombotic agent 135
PGI2 PLATELET RECEPTORS ARE AFFECTED BY CHOLESTEROL PHOSPHOLIPID MOLAR RATIO 134
Plasma and serum levels of D-dimer and their correlations with other hemostatic parameters in pregnancy. 131
Different methodologies for evaluating the effect of clopidogrel on platelet function in high-risk coronary artery disease patients 131
Thrombin generation after physical exercise 131
Influence of dietary fish intake on inflammatory and rheological parameters: an intervention study 130
Global platelet hyperreactivity and elevated C-reactive protein levels predict long term mortality in STEMI patients. 130
Comparison of five specific assays for determination of dabigatran plasma concentrations in patients enrolled in the START-Laboratory Register 130
Usefulness of lyophilized calibration plasmas for International Normalized Ratio determination with the bovine combined thromboplastin (Thrombotest): results of a collaborative study. 128
Effect of n-3 polyunsaturated fatty acid intake on phospholipid fatty acid composition in plasma and erythrocytes 127
eNOS gene influences platelet phenotype in acute coronary syndrome patients on dual antiplatelet treatment 126
Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients 125
Severe bleeding and absent ADP-induced platelet aggregation associated with inherited combined CalDAG-GEFI and P2Y12 deficiencies. 125
Totale 20.175
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.897
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.897
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022905 17 77 59 48 43 37 43 60 47 41 171 262
2022/20232.295 238 390 113 146 206 414 315 138 241 13 54 27
2023/2024884 19 107 146 43 68 152 16 157 19 43 58 56
2024/20255.521 173 539 439 829 1.592 933 57 271 272 138 136 142
2025/20265.828 599 754 326 306 673 257 705 390 365 353 148 952
2026/202722 22 0 0 0 0 0 0 0 0 0 0 0
Totale 23.731